These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Ranolazine Prevents Phenotype Development in a Mouse Model of Hypertrophic Cardiomyopathy. Coppini R; Mazzoni L; Ferrantini C; Gentile F; Pioner JM; Laurino A; Santini L; Bargelli V; Rotellini M; Bartolucci G; Crocini C; Sacconi L; Tesi C; Belardinelli L; Tardiff J; Mugelli A; Olivotto I; Cerbai E; Poggesi C Circ Heart Fail; 2017 Mar; 10(3):. PubMed ID: 28255011 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of NFE2L2-Antioxidant Response Element Pathway by Mitochondrial Reactive Oxygen Species Contributes to Development of Cardiomyopathy and Left Ventricular Dysfunction in Chagas Disease. Wen JJ; Porter C; Garg NJ Antioxid Redox Signal; 2017 Sep; 27(9):550-566. PubMed ID: 28132522 [TBL] [Abstract][Full Text] [Related]
13. p53-PGC-1α pathway mediates oxidative mitochondrial damage and cardiomyocyte necrosis induced by monoamine oxidase-A upregulation: role in chronic left ventricular dysfunction in mice. Villeneuve C; Guilbeau-Frugier C; Sicard P; Lairez O; Ordener C; Duparc T; De Paulis D; Couderc B; Spreux-Varoquaux O; Tortosa F; Garnier A; Knauf C; Valet P; Borchi E; Nediani C; Gharib A; Ovize M; Delisle MB; Parini A; Mialet-Perez J Antioxid Redox Signal; 2013 Jan; 18(1):5-18. PubMed ID: 22738191 [TBL] [Abstract][Full Text] [Related]
14. Preservation of Acyl Coenzyme A Attenuates Pathological and Metabolic Cardiac Remodeling Through Selective Lipid Trafficking. Goldenberg JR; Carley AN; Ji R; Zhang X; Fasano M; Schulze PC; Lewandowski ED Circulation; 2019 Jun; 139(24):2765-2777. PubMed ID: 30909726 [TBL] [Abstract][Full Text] [Related]
15. Evidence for a hyper-reductive redox in a sub-set of heart failure patients. Sairam T; Patel AN; Subrahmanian M; Gopalan R; Pogwizd SM; Ramalingam S; Sankaran R; Rajasekaran NS J Transl Med; 2018 May; 16(1):130. PubMed ID: 29776421 [TBL] [Abstract][Full Text] [Related]
16. Cardioprotective and antiapoptotic effects of heme oxygenase-1 in the failing heart. Wang G; Hamid T; Keith RJ; Zhou G; Partridge CR; Xiang X; Kingery JR; Lewis RK; Li Q; Rokosh DG; Ford R; Spinale FG; Riggs DW; Srivastava S; Bhatnagar A; Bolli R; Prabhu SD Circulation; 2010 May; 121(17):1912-25. PubMed ID: 20404253 [TBL] [Abstract][Full Text] [Related]
17. Blocking cardiac growth in hypertrophic cardiomyopathy induces cardiac dysfunction and decreased survival only in males. Luckey SW; Mansoori J; Fair K; Antos CL; Olson EN; Leinwand LA Am J Physiol Heart Circ Physiol; 2007 Feb; 292(2):H838-45. PubMed ID: 17012357 [TBL] [Abstract][Full Text] [Related]
18. Pathogenesis of Hypertrophic Cardiomyopathy is Mutation Rather Than Disease Specific: A Comparison of the Cardiac Troponin T E163R and R92Q Mouse Models. Ferrantini C; Coppini R; Pioner JM; Gentile F; Tosi B; Mazzoni L; Scellini B; Piroddi N; Laurino A; Santini L; Spinelli V; Sacconi L; De Tombe P; Moore R; Tardiff J; Mugelli A; Olivotto I; Cerbai E; Tesi C; Poggesi C J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28735292 [TBL] [Abstract][Full Text] [Related]
19. Impaired transcriptional activity of Nrf2 in age-related myocardial oxidative stress is reversible by moderate exercise training. Gounder SS; Kannan S; Devadoss D; Miller CJ; Whitehead KJ; Odelberg SJ; Firpo MA; Paine R; Hoidal JR; Abel ED; Rajasekaran NS PLoS One; 2012; 7(9):e45697. PubMed ID: 23029187 [TBL] [Abstract][Full Text] [Related]